Alembic Pharmaceuticals Ltd.
| BSE: 533573 | Sector: Health care |
| NSE: APLLTD | ISIN Code: INE901L01018 |
| BSE 00:00 | 21 Sep | 781.25 |
-2.25 (-0.29%) |
OPEN
784.00 |
HIGH
792.15 |
LOW
767.95 |
| NSE 00:00 | 21 Sep | 781.40 |
-0.30 (-0.04%) |
OPEN
782.50 |
HIGH
791.90 |
LOW
768.05 |
| OPEN | 784.00 |
| PREVIOUS CLOSE | 783.50 |
| VOLUME | 27383 |
| 52-Week high | 1150.00 |
| 52-Week low | 720.80 |
| P/E | 14.63 |
| Mkt Cap.(Rs cr) | 15,355 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Pharmaceuticals Ltd. (APLLTD) - Latest News & Headlines
-
Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months
3.05 pm | 27 Jul 2021 | Business Standard
Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results
-
Alembic Pharma dips 8% on disappointing June quarter results
9.54 am | 27 Jul 2021 | Business Standard
Ebitda (earnings before interest, taxes, depreciation, and amortization) margins declined 1258 basis points (bps) YoY to 17.8 per cent, due to higher ...
-
Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion
8.17 pm | 26 Jul 2021 | Business Standard
Firm's consolidated revenues from operations also fell marginally to Rs 1,326 cr in Q1FY22, from Rs 1,341 crore a year ago
-
Bata India, Escorts: Trading strategies for mid-cap losers of 2021
2.50 pm | 24 May 2021 | Business Standard
If these stocks manage to cross their significant resistances, the upside may result in a surge of over 5 per cent
-
Alembic Pharma falls 6% post March quarter results
10.04 am | 5 May 2021 | Business Standard
Alembic Pharma Q4FY21 operational performance was marginally below estimates, largely due to lower traction in US and Domestic Formulation (DF) sales
-
Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
8.24 pm | 4 May 2021 | Business Standard
Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%
-
Consolidation continues on D St; Sensex falls 465 pts; Nifty PSU Bank up 3%
4.20 pm | 4 May 2021 | Business Standard
Nearly 35 of the 50 constituents on the index ended the day in the red including Tata Consumer Products (down 4.3 per cent), Cipla, Reliance Industrie...
Quick Links for Alembic Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
